60,407 Shares in Oscar Health, Inc. $OSCR Bought by Quantbot Technologies LP

Quantbot Technologies LP purchased a new stake in Oscar Health, Inc. (NYSE:OSCR) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 60,407 shares of the company’s stock, valued at approximately $1,144,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Envestnet Asset Management Inc. grew its stake in shares of Oscar Health by 200.9% in the second quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock valued at $648,000 after buying an additional 20,171 shares in the last quarter. Udine Wealth Management Inc. lifted its position in Oscar Health by 138.4% during the 3rd quarter. Udine Wealth Management Inc. now owns 146,555 shares of the company’s stock worth $2,774,000 after acquiring an additional 85,083 shares in the last quarter. Q Fund Management Hong Kong Ltd purchased a new position in Oscar Health in the 3rd quarter worth approximately $5,940,000. Jump Financial LLC grew its position in Oscar Health by 798.3% in the second quarter. Jump Financial LLC now owns 1,441,506 shares of the company’s stock valued at $30,906,000 after acquiring an additional 1,281,032 shares in the last quarter. Finally, State of Michigan Retirement System acquired a new stake in Oscar Health in the third quarter valued at approximately $27,448,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Insider Activity at Oscar Health

In related news, insider Mario Schlosser sold 76,962 shares of the stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $17.01, for a total value of $1,309,123.62. Following the sale, the insider owned 350,180 shares of the company’s stock, valued at $5,956,561.80. This trade represents a 18.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold a total of 138,835 shares of company stock worth $2,298,269 in the last three months. 24.39% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on OSCR shares. Wells Fargo & Company dropped their price target on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research note on Thursday, November 13th. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research note on Thursday, January 22nd. Wall Street Zen raised shares of Oscar Health from a “sell” rating to a “hold” rating in a report on Saturday, February 14th. Raymond James Financial upgraded shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price objective on the stock in a research note on Thursday, February 12th. Finally, Stephens assumed coverage on shares of Oscar Health in a research report on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 target price for the company. Two investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $16.88.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $13.92 on Friday. The company has a market cap of $4.14 billion, a PE ratio of -8.00 and a beta of 1.91. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.80. The firm has a 50-day simple moving average of $14.64 and a 200 day simple moving average of $16.57. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.44.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by ($0.32). The company had revenue of $2.81 billion during the quarter, compared to the consensus estimate of $3.12 billion. Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The company’s revenue for the quarter was up 17.3% on a year-over-year basis. During the same period last year, the business posted ($0.62) EPS. On average, sell-side analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.